PF-06412562
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for PF-06412562, covering 2014-03-28 to 2019-02-04. Get the full timeline:
Most recent: Clinical Trial Update: A Study To Examine Safety, Pharmacokinetics, And Pharmacodynamic Of Pf 06412562 In Subjects With Schizophrenia [Phase 1]